SCHEMBL20170665

SCHEMBL20170665

COC1=CC2CCc3ccc(OC)c(O)c3C2CC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
MRGPRX2 Q96LB1 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
RAD52 P43351 1/20 0.35
PMP22 Q01453 1/20 0.35
GAA P10253 1/20 0.35
DRD1 P21728 4/20 0.34
DRD2 P14416 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20170653 0.74 GAA (0.42) CYP3A4CYP2D6KDM4EMAPTBCHE
SCHEMBL18473422 0.73 KDM4E (0.37) CYP3A4CYP2D6KDM4EMAPTMRGPRX2
SCHEMBL26205690 0.72 BCHE (0.39) CYP3A4CYP2D6KDM4EMAPTBCHE
SCHEMBL20170881 0.70 CYP1A2 (0.36) CYP3A4CYP2D6KDM4EMAPTBCHE
SCHEMBL14521377 0.65 MAPT (0.46) CYP3A4CYP2D6KDM4EMAPTMRGPRX2
SCHEMBL18473561 0.63 GAA (0.37) CYP3A4CYP2D6BCHEACHECYP1A2
SCHEMBL20170704 0.62 DRD1 (0.38) CYP3A4CYP2D6KDM4EL3MBTL1BCHE
SCHEMBL15800519 0.62 KDM4E (0.53) CYP3A4CYP2D6KDM4EMAPTCYP1A2
SCHEMBL29885479 0.62 MAOA (0.54) CYP2D6KDM4EBCHEACHEHIF1A
SCHEMBL21081223 0.61 ACHE (0.34) CYP3A4CYP2D6KDM4EMAPTBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2453895-B1 (+) - MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF MALLINCKRODT LLC (US) 2018-05-23 EP disclosed